Healio
Healio
Issue: April 2011
April 01, 2011
1 min read
Save

NIH announces new plan to combat diabetes

Issue: April 2011
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A new strategy to guide diabetes-related research over the next decade with the greatest potential to benefit Americans who are living with or at risk for diabetes and its complications has been announced by the NIH.

The plan, Advances and Emerging Opportunities in Diabetes Research: A Strategic Planning Report of the Diabetes Mellitus Interagency Coordinating Committee, will focus on 10 areas of diabetes research. According to the NIH, the goal is to accelerate discovery on several fronts, including:

  • the relationship between obesity and type 2 diabetes, and how both conditions may be affected by genetics and environment;
  • the autoimmune mechanisms at work in type 1 diabetes;
  • the biology of beta cells, which released insulin in the pancreas;
  • development of artificial pancreas technologies to improvement management of blood glucose levels;
  • prevention of complications of diabetes that affect the heart, eyes, kidneys, nervous system and other organs; and
  • the reduction of the impact of diabetes on groups disproportionately affected, including the elderly and racial/ethnic minorities.

“By setting priorities and identifying the most compelling research opportunities, the strategic plan will guide NIH, other federal agencies and the investigative community in efforts to improve diabetes treatments and identify ways to keep more people healthy,” Griffin P. Rodgers, MD, director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), said in a press release. A federal work group led by the NIDDK developed the strategic plan.

Under the plan, the NIH will continue to emphasize clinical research in humans, which already has led to highly effective methods for managing diabetes and preventing complications, Rodgers said. The strategy includes plans for addressing with type 1 and type 2 diabetes as well as gestational diabetes.

The NIH strategic plan is available here.

Twitter Follow EndocrineToday.com on Twitter.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.